JP2015517311A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015517311A5 JP2015517311A5 JP2015511803A JP2015511803A JP2015517311A5 JP 2015517311 A5 JP2015517311 A5 JP 2015517311A5 JP 2015511803 A JP2015511803 A JP 2015511803A JP 2015511803 A JP2015511803 A JP 2015511803A JP 2015517311 A5 JP2015517311 A5 JP 2015517311A5
- Authority
- JP
- Japan
- Prior art keywords
- cells
- oct4
- mrna
- reprogramming
- cell
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 210000004027 cell Anatomy 0.000 claims description 44
- 238000000034 method Methods 0.000 claims description 42
- 108020004999 messenger RNA Proteins 0.000 claims description 18
- 230000008672 reprogramming Effects 0.000 claims description 16
- 210000001082 somatic cell Anatomy 0.000 claims description 12
- 230000023603 positive regulation of transcription initiation, DNA-dependent Effects 0.000 claims description 10
- 108091032973 (ribonucleotides)n+m Proteins 0.000 claims description 6
- 101000687905 Homo sapiens Transcription factor SOX-2 Proteins 0.000 claims description 6
- 102100024270 Transcription factor SOX-2 Human genes 0.000 claims description 6
- 101710126211 POU domain, class 5, transcription factor 1 Proteins 0.000 claims description 5
- 102000040650 (ribonucleotides)n+m Human genes 0.000 claims description 4
- 101001139134 Homo sapiens Krueppel-like factor 4 Proteins 0.000 claims description 4
- 101001030211 Homo sapiens Myc proto-oncogene protein Proteins 0.000 claims description 4
- 101000984042 Homo sapiens Protein lin-28 homolog A Proteins 0.000 claims description 4
- 102100020677 Krueppel-like factor 4 Human genes 0.000 claims description 4
- 102100038895 Myc proto-oncogene protein Human genes 0.000 claims description 4
- 102100025460 Protein lin-28 homolog A Human genes 0.000 claims description 4
- 101001023030 Toxoplasma gondii Myosin-D Proteins 0.000 claims description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 4
- 210000004962 mammalian cell Anatomy 0.000 claims description 4
- 101100239628 Danio rerio myca gene Proteins 0.000 claims description 3
- 108700021430 Kruppel-Like Factor 4 Proteins 0.000 claims description 3
- 101100247004 Rattus norvegicus Qsox1 gene Proteins 0.000 claims description 3
- 101150111214 lin-28 gene Proteins 0.000 claims description 3
- 210000002894 multi-fate stem cell Anatomy 0.000 claims description 3
- 101100411708 Danio rerio rarga gene Proteins 0.000 claims description 2
- 108010068250 Herpes Simplex Virus Protein Vmw65 Proteins 0.000 claims description 2
- 102100035423 POU domain, class 5, transcription factor 1 Human genes 0.000 claims description 2
- 108020004459 Small interfering RNA Proteins 0.000 claims description 2
- 230000032459 dedifferentiation Effects 0.000 claims description 2
- 201000010099 disease Diseases 0.000 claims description 2
- 208000035475 disorder Diseases 0.000 claims description 2
- 230000004927 fusion Effects 0.000 claims description 2
- 210000005260 human cell Anatomy 0.000 claims description 2
- 238000000338 in vitro Methods 0.000 claims description 2
- 210000004263 induced pluripotent stem cell Anatomy 0.000 claims description 2
- 230000001939 inductive effect Effects 0.000 claims description 2
- 230000002401 inhibitory effect Effects 0.000 claims description 2
- 108091070501 miRNA Proteins 0.000 claims description 2
- 239000002679 microRNA Substances 0.000 claims description 2
- 230000001105 regulatory effect Effects 0.000 claims description 2
- 208000024891 symptom Diseases 0.000 claims description 2
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261646292P | 2012-05-13 | 2012-05-13 | |
| US61/646,292 | 2012-05-13 | ||
| PCT/US2013/040814 WO2013173248A2 (en) | 2012-05-13 | 2013-05-13 | Feeder-free derivation of human-induced pluripotent stem cells with synthetic messenger rna |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017137655A Division JP6530452B2 (ja) | 2012-05-13 | 2017-07-14 | 合成メッセンジャーｒｎａを使用したヒト人工多能性幹細胞のフィーダーフリー誘導 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2015517311A JP2015517311A (ja) | 2015-06-22 |
| JP2015517311A5 true JP2015517311A5 (enExample) | 2016-06-23 |
| JP6448531B2 JP6448531B2 (ja) | 2019-01-09 |
Family
ID=49548771
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015511803A Active JP6448531B2 (ja) | 2012-05-13 | 2013-05-13 | 合成メッセンジャーｒｎａを使用したヒト人工多能性幹細胞のフィーダーフリー誘導 |
| JP2017137655A Active JP6530452B2 (ja) | 2012-05-13 | 2017-07-14 | 合成メッセンジャーｒｎａを使用したヒト人工多能性幹細胞のフィーダーフリー誘導 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017137655A Active JP6530452B2 (ja) | 2012-05-13 | 2017-07-14 | 合成メッセンジャーｒｎａを使用したヒト人工多能性幹細胞のフィーダーフリー誘導 |
Country Status (9)
| Country | Link |
|---|---|
| EP (2) | EP3561054B1 (enExample) |
| JP (2) | JP6448531B2 (enExample) |
| KR (2) | KR102081811B1 (enExample) |
| CN (2) | CN104520424B (enExample) |
| AU (2) | AU2013263101B2 (enExample) |
| CA (1) | CA2872688C (enExample) |
| DK (1) | DK2850179T3 (enExample) |
| ES (2) | ES2951822T3 (enExample) |
| WO (1) | WO2013173248A2 (enExample) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK3260140T3 (da) | 2011-12-05 | 2021-04-19 | Factor Bioscience Inc | Fremgangsmåder og produkter til transficering af celler |
| US8497124B2 (en) | 2011-12-05 | 2013-07-30 | Factor Bioscience Inc. | Methods and products for reprogramming cells to a less differentiated state |
| EP3561054B1 (en) * | 2012-05-13 | 2023-07-05 | Allele Biotechnology And Pharmaceuticals, Inc. | Feeder-free derivation of human-induced pluripotent stem cells with synthetic messenger rna |
| US10155929B2 (en) | 2012-05-13 | 2018-12-18 | Allele Biotechnology & Pharmaceuticals, Inc. | Feeder-free derivation of human-induced pluripotent stem cells with synthetic messenger RNA |
| US10119150B2 (en) | 2012-05-13 | 2018-11-06 | Allele Biotechnology & Pharmaceuticals, Inc. | Feeder-free Derivation of human-induced pluripotent stem cells with synthetic messenger RNA |
| BR122019025681B1 (pt) | 2012-11-01 | 2023-04-18 | Factor Bioscience Inc | Método para inserir uma sequência de ácido nucleico em uma localização segura de um genoma de uma célula |
| WO2015117021A1 (en) | 2014-01-31 | 2015-08-06 | Factor Bioscience Inc. | Methods and products for nucleic acid production and delivery |
| EP3543339A1 (en) | 2015-02-13 | 2019-09-25 | Factor Bioscience Inc. | Nucleic acid products and methods of administration thereof |
| EP4470544A3 (en) * | 2015-11-23 | 2025-06-18 | The Regents of the University of Colorado, a body corporate | Methods and compositions for reprogramming cells |
| CN109803977B (zh) | 2016-08-17 | 2023-03-17 | 菲克特生物科学股份有限公司 | 核酸产品及其施用方法 |
| CA3043372A1 (en) | 2016-11-16 | 2018-05-24 | Allele Biotechnology & Pharmaceuticals, Inc. | Induction of pancreatic beta cells by stem cell differentiation with rna |
| AU2017363142B2 (en) * | 2016-11-16 | 2024-05-30 | Allele Biotechnology & Pharmaceuticals, Inc. | Induction of hepatocytes by stem cell differentiation with RNA |
| KR102122336B1 (ko) * | 2018-10-26 | 2020-06-12 | 서울시립대학교 산학협력단 | 세포전환용 rna 나노입자를 이용한 유도만능줄기세포의 제조방법 |
| EP3969571A4 (en) | 2019-05-14 | 2023-05-24 | Aleph Farms Ltd. | AGGREGATES OF PLURIPOTENT CELLS AND THEIR USE |
| WO2021003462A1 (en) | 2019-07-03 | 2021-01-07 | Factor Bioscience Inc. | Cationic lipids and uses thereof |
| US10501404B1 (en) | 2019-07-30 | 2019-12-10 | Factor Bioscience Inc. | Cationic lipids and transfection methods |
| US20230053060A1 (en) * | 2020-01-24 | 2023-02-16 | I Peace, Inc. | Method for manufacturing induced pluripotent stem cells |
| JP2022104813A (ja) | 2020-12-29 | 2022-07-11 | アイ ピース，インコーポレイテッド | リプログラミング因子を導入された細胞の培養方法 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5260432A (en) * | 1989-06-22 | 1993-11-09 | Sloan-Kettering Institute For Cancer Research | Human gamma retinoic acid receptor DNA |
| CN105671065A (zh) * | 2008-06-13 | 2016-06-15 | 怀特黑德生物医学研究所 | 细胞编程和重编程 |
| EP2881461A1 (en) * | 2008-11-21 | 2015-06-10 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. | Reprogramming cells toward a pluripotent state |
| ES2539487T3 (es) * | 2009-11-04 | 2015-07-01 | Cellular Dynamics International, Inc. | Reprogramación episómica con compuestos químicos |
| EP3287525B1 (en) * | 2009-12-07 | 2019-10-23 | The Trustees of The University of Pennsylvania | Rna preparations comprising purified modified rna for reprogramming cells |
| CN102190731B (zh) * | 2010-03-09 | 2016-01-27 | 中国科学院上海生命科学研究院 | 用人工转录因子诱导产生多能干细胞 |
| WO2012012708A1 (en) * | 2010-07-22 | 2012-01-26 | Regents Of The University Of Minnesota | Induced pluripotent stem cells |
| US8940945B2 (en) * | 2010-07-23 | 2015-01-27 | University Of South Florida | Materials and methods for reduction of protein tau and treatment of neurodegenerative diseases |
| CN102417894B (zh) * | 2011-10-21 | 2013-06-05 | 中国科学院广州生物医药与健康研究院 | 一种提高诱导生成多能性干细胞效率的方法 |
| US10155929B2 (en) * | 2012-05-13 | 2018-12-18 | Allele Biotechnology & Pharmaceuticals, Inc. | Feeder-free derivation of human-induced pluripotent stem cells with synthetic messenger RNA |
| EP3561054B1 (en) * | 2012-05-13 | 2023-07-05 | Allele Biotechnology And Pharmaceuticals, Inc. | Feeder-free derivation of human-induced pluripotent stem cells with synthetic messenger rna |
| CN103739718B (zh) * | 2014-01-16 | 2017-02-08 | 中国科学院动物研究所 | 用于诱导多能干细胞的融合蛋白及其使用方法 |
-
2013
- 2013-05-13 EP EP19163001.1A patent/EP3561054B1/en active Active
- 2013-05-13 ES ES19163001T patent/ES2951822T3/es active Active
- 2013-05-13 CN CN201380025010.4A patent/CN104520424B/zh active Active
- 2013-05-13 CA CA2872688A patent/CA2872688C/en active Active
- 2013-05-13 CN CN201910468645.0A patent/CN110241087B/zh active Active
- 2013-05-13 AU AU2013263101A patent/AU2013263101B2/en active Active
- 2013-05-13 DK DK13790064.3T patent/DK2850179T3/da active
- 2013-05-13 KR KR1020147034726A patent/KR102081811B1/ko active Active
- 2013-05-13 JP JP2015511803A patent/JP6448531B2/ja active Active
- 2013-05-13 WO PCT/US2013/040814 patent/WO2013173248A2/en not_active Ceased
- 2013-05-13 EP EP13790064.3A patent/EP2850179B1/en active Active
- 2013-05-13 ES ES13790064T patent/ES2729563T3/es active Active
- 2013-05-13 KR KR1020207004988A patent/KR102215413B1/ko active Active
-
2017
- 2017-07-14 JP JP2017137655A patent/JP6530452B2/ja active Active
-
2019
- 2019-05-13 AU AU2019203335A patent/AU2019203335B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2015517311A5 (enExample) | ||
| Han et al. | Direct reprogramming of fibroblasts into neural stem cells by defined factors | |
| JP2016521541A5 (enExample) | ||
| Brouwer et al. | Choices for induction of pluripotency: recent developments in human induced pluripotent stem cell reprogramming strategies | |
| Miyawaki et al. | Tumour resistance in induced pluripotent stem cells derived from naked mole-rats | |
| Downing et al. | Biophysical regulation of epigenetic state and cell reprogramming | |
| Rony et al. | Inducing pluripotency in vitro: recent advances and highlights in induced pluripotent stem cells generation and pluripotency reprogramming | |
| JP6530452B2 (ja) | 合成メッセンジャーｒｎａを使用したヒト人工多能性幹細胞のフィーダーフリー誘導 | |
| Huang et al. | Concurrent expression of Oct4 and Nanog maintains mesenchymal stem-like property of human dental pulp cells | |
| Poleganov et al. | Efficient reprogramming of human fibroblasts and blood-derived endothelial progenitor cells using nonmodified RNA for reprogramming and immune evasion | |
| Adler et al. | Nonviral direct conversion of primary mouse embryonic fibroblasts to neuronal cells | |
| US9447408B2 (en) | Method of efficiently establishing induced pluripotent stem cells | |
| Wu et al. | Clinical grade iPS cells: need for versatile small molecules and optimal cell sources | |
| Tanabe | Signaling involved in stem cell reprogramming and differentiation | |
| Sato et al. | Core transcription factors promote induction of PAX3-positive skeletal muscle stem cells | |
| Pfaff et al. | miRNAs involved in the generation, maintenance, and differentiation of pluripotent cells | |
| Abdelalim et al. | The p53 inhibitor, pifithrin-α, suppresses self-renewal of embryonic stem cells | |
| JP2014515258A5 (enExample) | ||
| Sun et al. | MiR-98-5p regulates myocardial differentiation of mesenchymal stem cells by targeting TBX5. | |
| Kopecky et al. | Regeneration of hair cells: making sense of all the noise | |
| WO2021251466A1 (ja) | 効率的な人工多能性幹細胞の作製方法 | |
| Birbrair | Molecular players in iPSC technology | |
| JP6433902B2 (ja) | 初期化幹細胞 | |
| Lou et al. | Reprogramming of mouse cochlear cells by transcription factors to generate induced pluripotent stem cells | |
| Nakhaei-Rad et al. | New windows to enhance direct reprogramming of somatic cells towards induced pluripotent stem cells |